Novartis booth at AACR 2026
Biotech

Novartis to pay $1.1B upfront for Myricx to expand ADC pipeline

Novartis is pushing deeper into ADC development, paying $1.1 billion upfront to buy Myricx Bio for a pipeline based on a novel payload.
Nick Paul Taylor Jul 6, 2026 5:10am
Genentech booth at AACR 2026

Genentech sees 103 layoffs, pens $490M breast cancer collab

Jul 6, 2026 7:30am
ArticlePrimaryImagejpg

Can We Outrun Cancer's Evolution? Why We Need a New Approach

Brought to you by BrYet US, Inc.
AZ

AstraZeneca pays CSPC $30M to form kidney drug discovery pact

Jul 3, 2026 8:00am
Heart

Scribe notes IPO plan to push lipid-lowering meds through clinic

Jul 6, 2026 7:54am
fundraise tracker 2026

Fierce Biotech Fundraising Tracker '26: Celea scores $180M

Jul 6, 2026 5:00am
More News

Fierce Biotech Layoff Tracker 2026: BioCryst, Biogen, & more

Jul 6, 2026 8:00am

United Therapeutics pays $140M for thymic cell therapy startup

Jul 3, 2026 5:49am

Roche orchestrates phase 3 lung cancer win over Amgen and BMS

Jul 2, 2026 8:30am

Fosun pays $32M to join Lilly and Novartis in psoriasis market

Jul 2, 2026 8:30am